CellWell record HH-137092
Effects of vitamin K2 supplementation on atherogenic status of individuals with type 2 diabetes: a randomized controlled trial
Fatemeh Rahimi Sakak; Nazanin Moslehi; Hengameh Abdi; Parvin Mirmiran
2021
In plain language
In a 12-week randomized trial, 360 μg/day of vitamin K2 (MK-7) did not significantly improve insulin-resistance-related cardiovascular risk indexes in adults with type 2 diabetes after adjusting for baseline values.
- Evidence
- Established
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-137092
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.